The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Global Glucagon Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Glucagon market size is expected to reach $ 1013 million by 2032, rising at a market growth of 6.0% CAGR during the forecast period (2026-2032). Glucagon is a metabolic hormone secreted by...
January 2026
111 pages
Global Ibuprofen Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Ibuprofen market size is expected to reach $ 124 million by 2032, rising at a market growth of 2.6% CAGR during the forecast period (2026-2032). Ibuprofen is an API which is used to produce...
January 2026
109 pages
Global Tylosin Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Tylosin market size is expected to reach $ 1729 million by 2032, rising at a market growth of 4.5% CAGR during the forecast period (2026-2032). Global core Tylosin manufacturers include Ela...
January 2026
105 pages
Hemophilia Market - Forecast from 2026 to 2031
US$ 3,950.00
The hemophilia market is expected to grow at a 6.42% CAGR, achieving USD 17.846 billion in 2031 from USD 12.285 billion in 2025. The hemophilia market is a specialized and dynamic segment within the g...
January 2026
149 pages
Gastroparesis Treatment Market - 2024-2033
US$ 2,999.00
The Gastroparesis Treatment Market was valued at US$ 7.5 billion in 2024 and is anticipated to reach US$ 11.03 billion by 2033, at a CAGR of 0.0442 from 2026 to 2032. The report delivers in-depth insi...
January 2026
223 pages
Male Hypogonadism Market - 2024-2032
US$ 2,999.00
The Male Hypogonadism Market was valued at US$ 3.56 billion in 2024 and is anticipated to reach US$ 5.38 billion by 2032, at a CAGR of 0.054 from 2026 to 2032. The report delivers in-depth insights in...
January 2026
223 pages
Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Polyenes, Allylamines, Echinocandins), By Indication, By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, according to a new report by Grand ... due to increasing drug resistance of the Candida species to Azoles North America held the largest market share in 2017. The growth of the market can be attributed ...
January 2026
150 pages
Nanomedicine Market - Forecast from 2026 to 2031
US$ 3,950.00
Nanomedicine Market, sustaining a 9.91% CAGR, is projected to expand to USD 479.692 billion in 2031 from USD 272.056 billion in 2025. The nanomedicine market represents a transformative frontier in he...
January 2026
146 pages
Short Bowel Syndrome Market - Forecast from 2026 to 2031
US$ 3,950.00
The short bowel syndrome market, at a 6.85% CAGR, is projected to increase from USD 1.953 billion in 2025 to USD 2.906 billion in 2031. The Short Bowel Syndrome (SBS) market is poised for steady growt...
January 2026
153 pages
Sickle Cell Disease Treatment Market - 2024-2033
US$ 2,999.00
The Sickle Cell Disease Treatment Market was valued at US$ 2.99 billion in 2024 and is anticipated to reach US$ 9.97 billion by 2033, at a CAGR of 0.148 from 2026 to 2032. The report delivers in-depth...
January 2026
210 pages
